Tin tức & Cập nhật

Aspirin-statin combo lowers hepatocellular carcinoma incidence
Aspirin-statin combo lowers hepatocellular carcinoma incidence
09 Apr 2022

Daily use of aspirin reduces the risk of incident hepatocellular carcinoma (HCC), while the combination of daily aspirin use and statin results in a lower incidence of HCC, which suggests a beneficial interaction, according to a study. In addition, no excess oesophageal variceal haemorrhage (VH) is seen among daily aspirin users compared with nonusers.

Aspirin-statin combo lowers hepatocellular carcinoma incidence
09 Apr 2022